Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1990-02-20
1993-05-25
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 245, C07H 1700, A61K 3170
Patent
active
052141365
ABSTRACT:
Oligonucleotide sequences modified by conjugation to at least one unsubstituted or substituted anthraquinone at other than the 5' terminus have favorable properties in enhancing hybridization to target DNA or RNA without loss of specificity and show enhanced stability to nucleases.
REFERENCES:
Chem. Abst. 114: 78183d, 1991.
Chem. Abst. 114: 43432g, 1991.
Ogilvie et al., Pure and Appl. Chem. (1987) 59(3):325-330.
Froehler et al., Nucleic Acids Res. (1986) 14(13):5399-5407.
Asseline et al., Tetrahedron Letters (1989) 30(19): 2521-2524.
Bayard et al., Biochemistry (1986) 25:3730-3736.
Lemaitre et al., Nucleosides and Nucleotides (1987) 6 (1&2):311-315.
Zuckerman et al., Nucleic Acids Res. (1987) 15(13):5305-5321.
Lancelot et al., Biochemistry (1985) 24:2521-2529.
Asseline et al., Proc. Natl. Acad. Sci. (1984) 81:3297-3301.
Mori et al., FEBS Letters (1989) 249(2):213-218.
van der Krol et al., Biotechniques (1988) 6(10):958-976.
Stein et al., Cancer Res. (1988) 48:2659-2668.
Lin Kuei-Ying
Matteucci Mark
Gilead Sciences, Inc.
Rollins John W.
LandOfFree
Anthraquinone-derivatives oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anthraquinone-derivatives oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthraquinone-derivatives oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-898017